Eefke Petersen - Concepedia

Author

Eefke Petersen

Also Known As

Dimitrios Karakasis, E J Petersen, E Petersen, E. J. Petersen, E. Petersen, E.J. Petersen, Eefke J Petersen, Eefke J. Petersen, Eefke Petersen, Johan Maertens

149

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Radboud University Nijmegen Radboud University Medical Center Erasmus MC Cancer Institute Leiden University Medical Center

About

Eefke Petersen is an author at University Medical Center Utrecht specializing in medicine, hematology, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	31	1.4K
2	Health Sciences	10	10	373
3	Natural Sciences	2	2	42
4	Public Health	1	1	20
5	Biochemistry	1	1	10

Eefke Petersen

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond, New England Journal of Medicine	2015	605
Cardiovascular Disease After Hodgkin Lymphoma Treatment Frederika A. van Nimwegen, Michael Schaapveld, Cécile P.M. Janus, JAMA Internal Medicine	2015	481
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis Rick Admiraal, Stefan Nierkens, Moniek A. de Witte, The Lancet Haematology Survival OutcomesTransplantationAutoimmune DiseaseMarrow TransplantationAnti-thymocyte Globulin Exposure	2017	209
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation Frédéric Baron, Myriam Labopin, Dietger Niederwieser, Leukemia Graft-versus-host DiseaseTransplantationMarrow TransplantationAcute Myeloid LeukemiaStem Cell Transplantation	2012	187
Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma Leo F. Verdonck, A. W. Dekker, Henk M. Lokhorst, Blood	1997	162
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation Donal P. McLornan, Richard Szydlo, Linda Köster, Biology of Blood and Marrow Transplantation	2019	94
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients Simone de Vries, Michael Schaapveld, Cécile P.M. Janus, JNCI Journal of the National Cancer Institute	2020	90
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study Effie W. Petersdorf, Mary Carrington, Colm Ó’hUigín, The Lancet Haematology Retrospective Cohort StudyGraft-versus-host DiseaseTransplantationAutoimmune DiseaseMarrow Transplantation	2019	84
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation Laurent Pascal, Luciana Tucunduva, Annalisa Ruggeri, Blood	2015	75
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells L.C.J. te Boome, C. Mansilla, Lotte E. van der Wagen, Leukemia Translational MedicineSteroid-resistant Acute GvhdCell TherapyMedicineStem Cells	2015	74

Page 1